Overview

Global Antiseptic and Disinfectant Market is estimated to value over USD 90.02 billion by 2026 end and register a CAGR of over 6.5% during the forecast period 2019 to 2026.

Disinfectants and antiseptic are products which are used to prevent the rise of microorganisms when it interacts with an inanimate object or living tissue. An antiseptic is a chemical element which takes control over the growth of microorganisms and a disinfectant is a chemical element that keeps infections at bay by disintegrating micro-organisms that are harmful. There are many advantages associated with disinfectants and antiseptic that include affordability, stability with chemicals and lack of staining with acceptable odor and colour. Disinfectants and antiseptics are used in hospital settings for an array of varied hard surface and topical applications.

The antiseptic and disinfectant market growth can be credited the boost in healthcare expenditure, curating innovative healthcare amenities, the surge of hospital related infections and the rise in hygiene maintenance on a global scale. In addition, there are also other components within this market such as the rising use of endoscope reprocessors as well as surgical units containing disinfected sprayers that are automated.  Given all these factors, the market is expected to encounter a revitalized economic boost. However, the strict regulatory bodies may pose potential threats to the global market for antiseptic and disinfectant during the forecast timeline.

Going by the segmentation of the product, the antiseptic and disinfectant market is bifurcated into iodine, alcohols, hydrogen peroxide, silver, chlorine compounds, phenolic compounds, aldehydes, quaternary ammonium compounds and others. Phenolic and aldehydes compounds are projected to grow at an exponential rate. In the case of phenolic compounds, there are a number of advantages associated with it in comparison to hydrogen peroxide. 

In terms of the end user, the is divided into domestic users, healthcare providers and commercial users. The healthcare providers are likely to take control of the market and acquire significant market share. A great deal of utilization of medical instruments, the rise of hospital-related infections, and a surge in the healthcare expenditure in terms of the per capita income in both developed and developing companies alike, are among the components which are anticipated to expand the antiseptic and disinfectant market size. In addition, commercial users of this particular market may further catalyze the industry growth during the forecast time frame because of the effectiveness against bacteria that is vegetative and the associated fungi and viruses.

Major players who are dominating the market includes Cardinal Health, Kimberly-Clark Corporation, Johnson & Johnson, 3M, Reckitt Benckiser, Bio-Cide International Inc., STERIS plc, Novartis AG. Some of the features for their revitalized economic growth includes going forward with acquisitions and mergers and accepting partnerships to cement their standing in the market.

Antiseptic and Disinfectant Market Segmentation:

By Product

• Quaternary Ammonium Compounds
• Chlorine Compounds
• Alcohols
• Aldehydes
• Phenolic Compounds
• Hydrogen Peroxide
• Iodine
• Silver
• Others

By End-user

• Healthcare Providers
• Commercial Users
• Domestic Users

By Region

• Europe
• North America
• Asia Pacific
• Latin America
• Middle East & Africa

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the antiseptic and disinfectant market by product, by end user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East & Africa
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

Table of Contents

1 Introduction 

1.1 Objectives of the Study 

1.2 Market Definition 

        1.2.1 Markets Covered

        1.2.2 Years Considered for the Study

1.3 Currency 

1.4 Limitations 

1.5 Stakeholders 

2 Research Methodology 

2.1 Research Approach 

2.2 Research Data 

        2.2.1 Secondary Sources

                 2.2.1.1 Key Data From Secondary Sources

        2.2.2 Primary Sources

                 2.2.2.1 Key Data From Primary Sources

                 2.2.2.2 Breakdown of Primary Interviews

2.3 Market Size Estimation 

2.4 Market Breakdown and Data Triangulation 

2.5 Research Assumptions 

3 Executive Summary 

4 Market Overview

4.1. Introduction

        4.1.1. Modality  Definition

       4.1.2. Industry Evolution / Developments

4.2.  Overview

4.3. Market Dynamics

       4.3.1. Drivers

       4.3.2. Restraints

       4.3.3. Opportunity

4.4. Global Antiseptic and Disinfectant Market Analysis and Forecast, 2019–2026

       4.4.1. Market Revenue Projections (US$ Mn)

4.5. Market Outlook

4.6.Regulatory Scenarios

4.7. Distributor Analysis – by Company

4.8. List of Manufacturers  (Classified by Disinfectants Production Capabilities)

       4.8.1. High Level

       4.8.2. Low Level

       4.8.3. Middle Level

4.9. Pricing Comparison Analysis

       4.9.1. By Product

       4.9.2. By Company

5.Global Antiseptic and Disinfectant Market Analysis and Forecast, By Product

5.1. Introduction & Definition

5.2. Key Findings / Developments

5.3. Market Value Forecast by Product, 2019–2026

       5.3.1. Quaternary Ammonium Compounds

       5.3.2. Chlorine Compounds

       5.3.3. Alcohols

       5.3.4. Aldehydes

       5.3.5. Phenolic Compounds

       5.3.6. Hydrogen Peroxide

       5.3.7. Iodine

       5.3.8. Silver

       5.3.9. Others

6.Global Antiseptic and Disinfectant Market Analysis and Forecast, By End-user 

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value Forecast by End-user, 2019–2026

       6.3.1. Healthcare Providers 

       6.3.2. Commercial Users 

       6.3.3. Domestic Users

7.Global Antiseptic and Disinfectant Market Analysis and Forecast, By Region

7.1. Key Findings

7.2. Market Value Forecast, by Region

       7.2.1. North America 

       7.2.2. Europe 

       7.2.3. Asia Pacific 

       7.2.4. Latin America 

       7.2.5. Middle East & Africa 

8 Competition Landscape

8.1.Market Player – Market Presence (2018)

       8.1.1. Current Offerings

       8.1.2. Strategy

8.2.Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)

       8.2.1. Novartis AG

                 8.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                 8.2.1.2. Product Portfolio

                 8.2.1.3. SWOT Analysis

                 8.2.1.4. Financial Overview

                 8.2.1.5. Strategic Overview

       8.2.2. 3M Company

                 8.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                 8.2.2.2. Product Portfolio

                 8.2.2.3. SWOT Analysis

                 8.2.2.5. Strategic Overview

       8.2.3. Johnson & Johnson

                 8.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                 8.2.3.2. Product Portfolio

                 8.2.3.3. SWOT Analysis

                 8.2.3.4. Financial Overview

                 8.2.3.5. Strategic Overview

       8.2.4. STERIS plc

                 8.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                 8.2.4.2. Product Portfolio

                 8.2.4.3. SWOT Analysis

                 8.2.4.4. Financial Overview

                 8.2.4.5. Strategic Overview

       8.2.5. Getinge Group

                 8.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                 8.2.5.2. Product Portfolio

                 8.2.5.3. SWOT Analysis

                 8.2.5.4. Financial Overview

                 8.2.5.5. Strategic Overview

      8.2.6. Cardinal Health

                 8.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                 8.2.6.2. Product Portfolio

                 8.2.6.3. SWOT Analysis

                8.2.6.4. Financial Overview

                 8.2.6.5. Strategic Overview

      8.2.7. Becton, Dickinson And Company

                 8.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                 8.2.7.2. Product Portfolio

                 8.2.7.3. SWOT Analysis

                 8.2.7.4. Financial Overview

                 8.2.7.5. Strategic Overview

      8.2.8. Whiteley Corporation

                 8.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                8.2.8.2. Product Portfolio

                 8.2.8.3. SWOT Analysis

                 8.2.8.4. Financial Overview

                 8.2.8.5. Strategic Overview

      8.2.9. Kimberly-Clark

                 8.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                 8.2.9.2. Product Portfolio

                 8.2.9.3. SWOT Analysis

                 8.2.9.4. Financial Overview

                 8.2.9.5. Strategic Overview

       8.2.10. Others

9 Research Finding and Conclusion

10 Research Methodology

11 Research Data Source

Tables

Figures